[HTML][HTML] Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure
J Maizel, I Six, S Dupont, E Secq, B Dehedin… - Kidney international, 2013 - Elsevier
Elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels are associated
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
[引用][C] Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure
J Maizel, I Six, S Dupont, E Secq, B Dehedin… - Kidney …, 2013 - cir.nii.ac.jp
Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure
J Maizel, I Six, S Dupont, E Secq… - Kidney …, 2013 - kidney-international.org
Elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels are associated
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure
J Maizel, I Six, S Dupont, E Secq… - Kidney …, 2013 - pubmed.ncbi.nlm.nih.gov
Elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels are associated
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
[PDF][PDF] Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure
J Maizel, I Six, S Dupont, E Secq, B Dehedin… - Kidney …, 2013 - researchgate.net
RESULTS Serum biochemistry and hematocrit Biochemical, hematocrit, and body weight
data are presented in Table 1. At baseline (ie, 6 weeks after the initiation of CRF creation or …
data are presented in Table 1. At baseline (ie, 6 weeks after the initiation of CRF creation or …
Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure.
J Maizel, I Six, S Dupont, E Secq… - Kidney …, 2013 - search.ebscohost.com
Elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels are associated
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure.
J Maizel, I Six, S Dupont, E Secq, B Dehedin… - Kidney …, 2013 - europepmc.org
Elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels are associated
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …
with cardiovascular disease (CVD) in patients with chronic renal failure (CRF). The …